DK7584A - 3-amino-2-oxo-azetidiner og fremgangsmaade til fremstilling deraf - Google Patents

3-amino-2-oxo-azetidiner og fremgangsmaade til fremstilling deraf Download PDF

Info

Publication number
DK7584A
DK7584A DK7584A DK7584A DK7584A DK 7584 A DK7584 A DK 7584A DK 7584 A DK7584 A DK 7584A DK 7584 A DK7584 A DK 7584A DK 7584 A DK7584 A DK 7584A
Authority
DK
Denmark
Prior art keywords
radical
radicals
amino
alkyl
optionally substituted
Prior art date
Application number
DK7584A
Other languages
English (en)
Other versions
DK164404C (da
DK164404B (da
DK7584D0 (da
Inventor
Jean Georges Teutsch
Michel Klich
Jean-Francois Chantot
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of DK7584D0 publication Critical patent/DK7584D0/da
Publication of DK7584A publication Critical patent/DK7584A/da
Publication of DK164404B publication Critical patent/DK164404B/da
Application granted granted Critical
Publication of DK164404C publication Critical patent/DK164404C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • C07D257/06Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK007584A 1983-01-10 1984-01-09 3-amino-2-oxo-azetidinderivater, analogifremgangsmaade til fremstilling deraf samt laegemidler indeholdende derivaterne DK164404C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8300273A FR2539128A1 (fr) 1983-01-10 1983-01-10 Nouveaux derives de la 3-amino 2-oxoazetidine comportant en position 1 un radical heterocyclique azote, leur procede de preparation, leur application comme medicaments et les produits intermediaires necessaires a leur preparation
FR8300273 1983-01-10

Publications (4)

Publication Number Publication Date
DK7584D0 DK7584D0 (da) 1984-01-09
DK7584A true DK7584A (da) 1984-07-11
DK164404B DK164404B (da) 1992-06-22
DK164404C DK164404C (da) 1992-11-09

Family

ID=9284799

Family Applications (1)

Application Number Title Priority Date Filing Date
DK007584A DK164404C (da) 1983-01-10 1984-01-09 3-amino-2-oxo-azetidinderivater, analogifremgangsmaade til fremstilling deraf samt laegemidler indeholdende derivaterne

Country Status (11)

Country Link
EP (1) EP0114128B1 (da)
JP (2) JPS59130862A (da)
AT (1) ATE41661T1 (da)
CA (1) CA1244034A (da)
DE (1) DE3477382D1 (da)
DK (1) DK164404C (da)
ES (1) ES528742A0 (da)
FR (1) FR2539128A1 (da)
GR (1) GR79459B (da)
IE (1) IE56521B1 (da)
PT (1) PT77939B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0649696B2 (ja) * 1983-07-04 1994-06-29 富山化学工業株式会社 新規なアゼチジノン誘導体およびその塩類
AU581180B2 (en) * 1983-08-26 1989-02-16 E.R. Squibb & Sons, Inc. 1-(1h-tetrazol-5-ylalkoxy)-2-azetidinones
JPH075592B2 (ja) * 1984-06-25 1995-01-25 富山化学工業株式会社 新規なアゼチジノン誘導体およびその塩
JPH07108907B2 (ja) * 1984-06-25 1995-11-22 富山化学工業株式会社 新規なアゼチジノン誘導体またはその塩
FR2582308B1 (fr) * 1985-05-22 1987-10-09 Roussel Uclaf Nouveaux derives de la 3-amino 2-oxoazetidine comportant en position 1 un radical tetrazolyle substitue par un radical organique clivable, leur procede de preparation et leur application comme medicaments
FR2585021B2 (fr) * 1985-07-18 1989-05-19 Roussel Uclaf Nouveaux derives de la 3-amino 2-oxoazetidinone comportant, en position 1, un radical heterocyclique azote, leur procede de preparation et leur application comme medicaments
ATE66225T1 (de) * 1987-02-11 1991-08-15 Upjohn Co Neue n-1 substituierte beta-lactame als antibiotika.
US5006650A (en) * 1987-02-11 1991-04-09 The Upjohn Company Novel N-1 substituted beta-lactams as antibiotics
JPH02502455A (ja) * 1987-02-27 1990-08-09 ジ・アップジョン・カンパニー ピリドンカルボン酸または酸誘導体を含有する抗生物質β‐ラクタム
AU2125188A (en) * 1987-07-22 1989-02-13 Upjohn Company, The Therapeutically useful beta-lactams
US5015737A (en) * 1987-07-22 1991-05-14 The Upjohn Company Therapeutically useful beta-lactams
CN103012316B (zh) * 2012-11-29 2015-03-25 浙江工业大学 N-4-甲基-1,2,3-噻二唑-4-酰基-n-取代1,3,4-噻二唑基硫脲衍生物及其制备和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3468874A (en) * 1967-04-10 1969-09-23 R & L Molecular Research Ltd 6 - tetrazolylacetamido penicillanic and 7-tetrazolylacetamido cephalosporanic acids
US4186131A (en) * 1977-04-21 1980-01-29 Mead Johnson & Company Phenyltetrazolyloxy propanolamines
DE2946432A1 (de) * 1979-11-17 1981-06-11 Bayer Ag, 5090 Leverkusen Tetrazolyloxycarbonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung als herbizide
WO1982001873A1 (en) * 1980-12-05 1982-06-10 Takeda Chemical Industries Ltd 1-sulfo-2-oxoazetidine derivatives and process for their preparation
JPS588060A (ja) * 1981-06-29 1983-01-18 イ−・ア−ル・スクイブ・アンド・サンズ・インコ−ポレイテツド アリ−ルチオアゼチジノンスルホン酸塩類

Also Published As

Publication number Publication date
DK164404C (da) 1992-11-09
ES8407046A1 (es) 1984-08-16
IE840036L (en) 1984-07-10
EP0114128A1 (fr) 1984-07-25
JPH0678336B2 (ja) 1994-10-05
FR2539128B1 (da) 1985-05-03
DE3477382D1 (en) 1989-04-27
DK164404B (da) 1992-06-22
PT77939B (fr) 1986-06-18
EP0114128B1 (fr) 1989-03-22
DK7584D0 (da) 1984-01-09
CA1244034A (fr) 1988-11-01
IE56521B1 (en) 1991-08-28
PT77939A (fr) 1984-02-01
ATE41661T1 (de) 1989-04-15
FR2539128A1 (fr) 1984-07-13
JPS59130862A (ja) 1984-07-27
GR79459B (da) 1984-10-30
ES528742A0 (es) 1984-08-16
JPH0480912B2 (da) 1992-12-21
JPH03163076A (ja) 1991-07-15

Similar Documents

Publication Publication Date Title
DK7584A (da) 3-amino-2-oxo-azetidiner og fremgangsmaade til fremstilling deraf
AU586248B2 (en) (Meth)-acrylic acid esters and their use
FI102281B1 (fi) Menetelmä uusien erytromysiinijohdannaisten valmistamiseksi
DE69325262D1 (de) Vinylen-azaindolderivate und verfahren zu ihrer herstellung
DE69305322D1 (de) Salpetersäureester von 2-(2,6-dihalophenylamino)phenylessigsäurederivaten und verfahren zu ihrer herstellung
NO308792B1 (no) Derivater av valproinsyre og 2-valproensyreamider, farmasøytisk sammensetning derav og deres anvendelse for fremstilling av et farmasøytisk preparat
DE59205041D1 (de) Neue 3,5-di-tert.butyl-4-hydroxyphenyl-derivate, verfahren zu ihrer herstellung und arzneimittel
DK302689D0 (da) Sulfonamider og fremgangsmaade til fremstilling deraf samt laegemidler indeholdende disse forbindelser
ATE192143T1 (de) Substituierte 2,2-dimethyl-omega-phenoxysäure und ester, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE167187T1 (de) Chinuclidinestern, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
ATE112283T1 (de) Beta-d-phenylthioxyloside, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
DE3881407D1 (de) Cinnolin-karbonsaeure-amide und verfahren zu deren herstellung.
AU626095B2 (en) Hydroxyalkane carboxylic acid derivatives, their production and use
DE59610410D1 (de) Triazolyloxybenzyl-alkoxyacrylsäureester, Verfahren zu ihrer Herstellung und ihre Verwendung
ATE195145T1 (de) Synthese von homochiralen 2-hydroxysäuren
ATE123776T1 (de) Aminoalkylchromone, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen.
ATE61341T1 (de) N-substituierte, estergruppen enthaltende acrylamide.
ATE38041T1 (de) 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln.
DE69407042D1 (de) Psoralen-derivate, deren herstellung und verwendung als arzneimittel
ATE47839T1 (de) N-(2,6-disubstituierte aryl)-n'pyridinylharnstoffe, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen.
ATE121397T1 (de) Aminoalkylketonderivate, verfahren zu ihrer herstellung und ihre therapeutischen anwendungen.

Legal Events

Date Code Title Description
PBP Patent lapsed